MedPath

Prophylactic Cholecystectomy is Not Mandatory in Patients Candidate to the Resection for Small Intestine Neuroendocrine Neoplasms: a Propensity Score-matched and Cost-minimization Analysis

Completed
Conditions
Surgery
Neuroendocrine Tumors
Gut Tumor
Interventions
Procedure: Cholecystectomy
Registration Number
NCT04780737
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

To evaluate two competitive strategies in patients undergoing resection of Small-intestine Neuroendocrine neoplasms (Si-NEN): Prophylactic Cholecystectomy (PC) versus On-demand delayed cholecystectomy

Detailed Description

This is a retrospective study based on 230 Si-NENs candidates to the primary tumor resection. Patients were divided into two arms: PC and OC. Propensity score matching was performed, reporting the d value. The primary outcome was the re-hospitalization rate for any cause. The secondary endpoints were the re-hospitalization rate for biliary stone disease (BSD), the mean number of re-hospitalization (any cause and BSD), the complication rate (all and severe), and the total costs. A P-value \< 0.05 was considered significant, and NNT\< 10 was considered clinically relevant.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
230
Inclusion Criteria
  • patients with a diagnosis of Si-NEN;
  • resection of the primary tumor with or without concomitant cholecystectomy;
  • absence of a history of a biliary stone disease or cholecystectomy before Si-NEN diagnosis
Exclusion Criteria
  • presence of a history of a biliary stone disease or cholecystectomy before Si-NEN diagnosis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
On-demand cholecystectomyCholecystectomyPatient resected for primary ileal neuroendocrine tumor, treated with cholecystectomy in a different operation and only if needed, for the development of biliary stone disease
Prophylactic cholecystectomyCholecystectomyPatient who undergo resection of primary ileal neuroendocrine tumor and contemporarly cholecystectomy
Primary Outcome Measures
NameTimeMethod
re-hospitalization rate for any causethrough study completion, an average of 7 years

the re-hospitalization rate for any cause after primary tumor surgery

Secondary Outcome Measures
NameTimeMethod
mean number of re-hospitalization any causethrough study completion, an average of 7 years

the mean number of re-hospitalization for any cause after primary tumor surgery

re-hospitalization rate for biliary stone diseasethrough study completion, an average of 7 years

the re-hospitalization rate for biliary stone disease after primary tumor surgery

mean number of re-hospitalization biliary stone diseasethrough study completion, an average of 7 years

the mean number of re-hospitalization for biliary stone disease after primary tumor surgery

total coststhrough study completion, an average of 7 years

total costs for primary tumor surgery plus any re-hospitalization

COmplication ratethrough study completion, an average of 7 years

COmplication rate after primary tumor resection

© Copyright 2025. All Rights Reserved by MedPath